ArticleBMC biotechnology2022

Development of a human phage display-derived anti-PD-1 scFv antibody: an attractive tool for immune checkpoint therapy.

Sepideh Safaei Ghaderi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.